Your dose of OZEMPIC and other diabetes medicines may need to change because of: change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, fever, trauma, infection, surgery or because of other medicines you take
BioWorld News examines why the companies separated and where each is headed next: (Access this exclusive content with a Premium BioWorld subscription: Daniel Faga #biopharma #newco Clarivate for Life Sciences & Healthcare To view or add a comment, sign in Danish pharmaceuticals group Novo Nordisk, maker of the popular Ozempic and Wegovy anti-obesity drugs, announced Tuesday a "strategic partnership" with OpenAI to accelerate the development of new medications
Both are used in clinical practice and both work
As our recent feasibility work shows, fragment approaches are not automatically superior for long peptides